The early 1990s were known as the dark days of AIDS. After more than a decade of intensive research, the death rate from HIV infection remained at 100%.
News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.
